Apply on Employer Site

Kailera Therapeutics · 21 hours ago

Internship: Competitive Intelligence

Waltham, Massachusetts

Internship

Hybrid

Intern

$25/hr - $30/hr

Kailera is committed to developing therapies that transform lives and improve health. They are seeking a Competitive Intelligence Intern to gain hands-on experience in strategic analysis and competitive intelligence within the obesity treatment landscape, monitoring market dynamics and providing insights for strategic decisions.

BiotechnologyPharmaceuticalTherapeutics

Responsibilities

Track competitor activities, regulatory updates, and emerging innovations in obesity treatment

Prepare and distribute timely alerts on relevant news developments to senior leadership

Analyze competitor earnings calls and highlight key takeaways and strategic implications

Develop a comprehensive document summarizing major themes in the obesity market and propose strategic recommendations for Kailera

Maintain and update competitive intelligence trackers and databases

Qualification

Analytical skillsResearch skillsMicrosoft Office SuiteInterest in biotechInterest in pharmaceuticalsInterest in obesity treatmentCommunication skills

Required

Undergraduate student currently pursuing a degree in Life Sciences, Business, Economics, or related field

Strong interest in biotech, pharmaceuticals, and obesity treatment innovation

Excellent analytical, research, and communication skills

Ability to synthesize complex information into clear, actionable insights

Proficiency in Microsoft Office Suite (Excel, PowerPoint, Word)

Benefits

Comprehensive health coverage

Monthly wellness stipend

Flexible time off

Paid holidays

Year-end shutdown

Generous 401(k) match

Tuition reimbursement

Commuter benefits

Disability and life insurance

Annual bonus opportunities

Equity grants

Company

Kailera Therapeutics

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Founded in 2024

Waltham, Massachusetts, USA

51-200 employees

https://www.kailera.com

Funding

Current Stage

Growth Stage

Total Funding

$1B

Key Investors

Bain Capital Private Equity

2025-10-14Series B· $600M

2024-10-01Series A· $400M

Leadership Team

Ronald Renaud

President & CEO

Paul Burgess

Chief Operating Officer and Chief Business Officer

Recent News

GlobeNewswire

Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer

2026-01-05

GlobeNewswire

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

2025-12-24

masslive

Here’s what happened to Mass. startup investing in 2025

2025-12-17

Company data provided by crunchbase